Laman UtamaTWST • NASDAQ
add
Twist Bioscience Corp
$36.94
Selepas Waktu Dagangan:(0.00%)0.00
$36.94
Tutup: 26 Jun, 4:10:10 PTG GMT-4 · USD · NASDAQ · Penafian
Tutup sebelumnya
$36.99
Julat hari
$36.08 - $37.48
Julat tahun
$27.12 - $60.90
Permodalan pasaran
2.21B USD
Bilangan Purata
1.17J
Nisbah P/E
-
Hasil dividen
-
Pertukaran utama
NASDAQ
Berita pasaran
Kewangan
Penyata Pendapatan
Hasil
Pendapatan bersih
(USD) | Mac 2025info | Perubahan T/T |
---|---|---|
Hasil | 92.79J | 23.23% |
Perbelanjaan pengendalian | 87.59J | 9.80% |
Pendapatan bersih | -39.33J | 13.55% |
Margin untung bersih | -42.38 | 29.85% |
Pendapatan bagi setiap syer | -0.66 | 16.46% |
EBITDA | -35.16J | 13.38% |
Kadar cukai berkesan | -0.45% | — |
Kunci Kira-kira
Jumlah aset
Jumlah liabiliti
(USD) | Mac 2025info | Perubahan T/T |
---|---|---|
Pelaburan tunai dan jangka pendek | 257.15J | -12.34% |
Jumlah aset | 595.62J | -15.26% |
Jumlah liabiliti | 155.51J | 8.96% |
Jumlah ekuiti | 440.11J | — |
Syer tertunggak | 59.92J | — |
Harga kepada buku | 5.03 | — |
Pulangan pada aset | -17.26% | — |
Pulangan pada modal | -19.62% | — |
Aliran Tunai
Perubahan bersih dalam tunai
(USD) | Mac 2025info | Perubahan T/T |
---|---|---|
Pendapatan bersih | -39.33J | 13.55% |
Tunai daripada operasi | -12.99J | 33.14% |
Tunai daripada pelaburan | -1.43J | 72.79% |
Tunai daripada pembiayaan | 3.20J | 74.84% |
Perubahan bersih dalam tunai | -11.11J | 51.48% |
Aliran tunai bebas | -5.15J | 14.52% |
Perihal
Twist Bioscience is a public biotechnology company based in South San Francisco that manufactures synthetic DNA and DNA products for customers in a wide range of industries. Twist was founded in 2013 by Emily Leproust, Bill Banyai, and Bill Peck.
The company was represented by Leproust at a March 2021 tabletop exercise at the Munich Security Conference simulating an outbreak of weaponized monkeypox.
In May 2021, Twist Bioscience and Genome Project-Write launched a new CAD platform for whole genome design. The CAD will automate workflows to enable collaborative efforts critical for scale-up from designing plasmids to megabases across entire genomes. Wikipedia
Diasaskan
2013
Tapak web
Pekerja
923